IRBIT和LIMA1与上皮细胞SLC26A3 (DRA) 通过cAMP/ATP的刺激相关,并且对于这种刺激是必要的
Rafiquel Sarker1, Tatiana B Boronia2, Robert N Cole2
1Division of Gastroenterology and Hepatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
American journal of physiology. Cell physiology
|June 26, 2025
概括
这项研究揭示了一种新的DRA-IRBIT-LIMA1复合体,该复合体对于调节肠道阴离子分泌至关重要. 通过cAMP和Ca2+的急性刺激减少了DRA酸化,并增强了这个复杂的结构.
科学领域:
- 生理学 生理学 生理学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 皮质刷边界 (BB) 化物 ([公式:见文本]) 交换器,在腺瘤 (DRA) 中下调,对于肠道NaCl吸收和离子分泌至关重要.
- 了解DRA调节对于消化系统生理学和分泌性腹疾病至关重要,通常涉及升高的cAMP和/或Ca2+.
- 之前的研究强调了cAMP和Ca2+对DRA刺激的协同作用,但基本的调节机制仍然不清楚.
研究的目的:
- 调查DRA在Caco-2细胞中的急性调节机制,这些细胞受到高cAMP和Ca2+刺激.
- 确定与DRA相互作用的蛋白质及其在cAMP/Ca2+介导刺激中的作用.
- 在急性刺激过程中阐明潜在的DRA蛋白复合体的形成和功能.
主要方法:
- 利用Caco-2细胞模型在福斯科林 (cAMP) 和ATP (Ca2+) 刺激下研究DRA调节.
- 使用免疫沉 (IP) 识别与DRA相关的蛋白质.
- 研究了撞击 (KD) IRBIT1或LIMA1对DRA活动和本地化的影响.
主要成果:
- 在S563的DRA酸化在急性cAMP/ATP刺激后显著下降.
- 与伊诺西1,4,5-三酸盐 (IRBIT) 和LiM域和活性蛋白结合蛋白1 (LIMA1) 释放的伊诺西1,4,5-三酸盐受体结合蛋白被确定为DRA相互作用蛋白.
- IRBIT1或LIMA1的KD损害了cAMP/ATP刺激的DRA活性,并在血膜内增加了DRA,IRBIT和LIMA1的相关性.
结论:
- 发现了一种新型的DRA-IRBIT-LIMA1复合体,它在急性刺激肠道阴离子运输中起着关键作用.
- 这种复杂的形成,涉及DRA的膜局部增加,对于协同作用的cAMP和Ca2+诱导的DRA激活至关重要.
- 这些发现为分泌性腹的分子基础和潜在的治疗点提供了关键的见解.
相关概念视频
IP3/DAG Signaling Pathway
12.4K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.4K
Amplifying Signals via Second Messengers
7.2K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.2K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Intracellular Signaling Cascades
47.7K
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
47.7K
ATP Driven Pumps III: V-type Pumps
3.9K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.9K
Carrier-Mediated Transport
540
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
540


